Reviews in Endocrine & Metabolic Disorders

Papers
(The H4-Index of Reviews in Endocrine & Metabolic Disorders is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Phase angle in assessment and monitoring treatment of individuals with respiratory disease172
The multifaceted progenitor fates in healthy or unhealthy adipose tissue during obesity141
Vitamin D and hip protectors in osteosarcopenia: a combined hip fracture preventing approach122
Effectiveness and safety of continuous subcutaneous hydrocortisone infusion in managing adrenocortical insufficiency in adult patients: a systematic review104
Vitamin D regulation of immune function during covid-1987
Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity84
Interactions between emotions and eating behaviors: Main issues, neuroimaging contributions, and innovative preventive or corrective strategies76
Childhood obesity, metabolic syndrome, and oxidative stress: microRNAs go on stage71
Pitfalls in the lab assessment of hypopituitarism61
Endocrine risk factors for COVID-19: Endogenous and exogenous glucocorticoid excess59
Metabolomic signatures after bariatric surgery – a systematic review56
Impact of exercise training after bariatric surgery on cardiometabolic risk factors: a systematic review and meta-analysis of controlled trials53
The emerging role of transcription factor FOXP3 in thyroid cancer51
Application of radiomics and machine learning to thyroid diseases in nuclear medicine: a systematic review43
Periconceptional biomarkers for maternal obesity: a systematic review43
Interactions between nuclear receptors glucocorticoid receptor α and peroxisome proliferator–activated receptor α form a negative feedback loop39
Pregnancy in patients with adrenocortical carcinoma: a case-based discussion37
Rare forms of genetic paediatric adrenal insufficiency: Excluding congenital adrenal hyperplasia36
Towards precision medicine in bariatric surgery prescription36
Applying psycho-behavioural phenotyping in obesity characterization35
Progress, challenges and perspectives in the management of hypopituitarism34
Phase angle as a marker of outcome in hospitalized pediatric patients. A systematic review of the evidence (GRADE) with meta-analysis34
Traumatic brain injury and prolactin33
Adipogenic progenitors in different organs: Pathophysiological implications33
The kisspeptin system in and beyond reproduction: exploring intricate pathways and potential links between endometriosis and polycystic ovary syndrome32
The impact of hypoxia exposure on glucose homeostasis in metabolically compromised humans: A systematic review31
Diagnosis and management of secondary adrenal crisis31
Epigenetic programming for obesity and noncommunicable disease: From womb to tomb31
Evidence-based definition of hypoprolactinemia in European men aged 40–86 years: the European male ageing study30
Thyroid sequelae of COVID-19: a systematic review of reviews30
Replacement with sex steroids in hypopituitary men and women: implications for gender differences in morbidities and mortality30
Subclinical central hypothyroidism in patients with hypothalamic-pituitary disease: does it exist?30
0.021657943725586